Home > Boards > US Listed > Biotechs > Rexahn Pharmaceuticals, Inc. (REXN)

Split on May 5th 2017

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
maggie61 Member Profile
 
Followed By 28
Posts 2,191
Boards Moderated 0
Alias Born 03/21/12
160x600 placeholder
maggie61   Wednesday, 01/23/19 03:49:32 PM
Re: PennyWorld post# 3843
Post # of 3884 
Split on May 5th 2017
Rexahn Pharmaceuticals, Inc. (the “Company”) announced today that it has effected a one-for-ten reverse split (the “Reverse Stock Split”) of the Company’s outstanding shares of common stock, together with a corresponding proportional reduction in the number of authorized shares of the Company’s capital stock (the “Authorized Share Reduction”). To effectuate the Reverse Stock Split and the Authorized Share Reduction, the Company filed a Certificate of Amendment of the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware. Pursuant to and upon the effectiveness of the Amendment at 7:00 a.m., Eastern Standard Time, on May 5, 2017, each ten shares of the Company’s common stock, par value $0.0001 per share, issued and outstanding at the effective time were reclassified and combined into one share of common stock, par value $0.0001 per share, of the Company and the number of shares of common stock and preferred stock the Company is authorized to issue was reduced to 50 million and 10 million, respectively

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist